While the increase in expression observed did not correlate with patients’ stage, age, menopausal status, or ethnicity, the increase in EMP2-positive tumor cells following neoadjuvant therapy significantly correlated with tumor recurrence (p = 0.04; Table S1). The gene discussed is EMP2; the disease is neoplasm.